Hives patient community app wins excellence award

Data and technology company ERT has won a CPhI Pharma Award for Excellence in Patient Centricity for its patient community app, Target My Hives.

The app gives patients access to an online network of resources and health professionals with chronic urticaria (hives). This lets patients support each other and enables them to actively take control of their condition.

ERT says that the approach Target My Hives takes allows patients to learn from others like them how to manage their disease, set goals for themselves and share their results with each other.

Tara Dougal, acting head of content, Pharma at UBM EMEA, said: “The annual CPhI Pharma Awards celebrates thinkers and creators who are breaking new ground in the pharmaceutical industry. We’re pleased to recognise ERT with the Excellence in Patient Centricity Award for its commitment to delivering patient-focused innovations that drive the industry forward.”

“We’re honored to be recognized for creating this vital support network for chronic urticaria patients,” said Tim Davis, vice president, Digital Patient, ERT. “Previously, patients were typically left alone to cope with the condition. By enabling patients to use their own mobile devices to motivate and support each other, the community reduces their sense of isolation and enables them to take control of their condition, which we hope will ultimately result in improved health outcomes.”


Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via:

'Hives patient community app wins excellence award' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions